Recursion Pharmaceuticals, Inc. (RXRX)
3.43
+0.06
(+1.78%)
USD |
NASDAQ |
May 06, 16:00
3.41
-0.02
(-0.58%)
After-Hours: 04:19
Recursion Pharmaceuticals Total Liabilities (Quarterly) : 314.75M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Intellia Therapeutics, Inc. | 170.73M |
| Tango Therapeutics, Inc. | 63.83M |
| KalVista Pharmaceuticals, Inc. | 338.09M |
| Ionis Pharmaceuticals, Inc. | 2.959B |
| Quince Therapeutics, Inc. | 129.35M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.340B |
| Shareholders Equity (Quarterly) | 1.025B |
| Debt to Equity Ratio | 0.0706 |
| Current Ratio | 5.471 |
| Net Debt Paydown Yield | 0.44% |